CLINICAL_TRIALS
trial_result
· 2021-05-19
Clinical Trial Update: Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage [Phase 3]
Summary
A Phase 3 trial update regarding restarting direct oral anticoagulants after traumatic intracranial hemorrhage, with a protocol restart.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas at Austin | Conditions: Anticoagulants; Increased | Phase 3 | Status: UNKNOWN